AKT1 and breast cancer: In this study that also included MDA-MB-231 breast cancer cells, knockdown of ST6Gal1 resulted in decreased EMT characteristics in association with PI3K/AKT signaling (rather than Smads) and preservation of E-cadherin (Lu et al., 2014).